MEDISCA News at Your Fingertips

MONTREAL, Q.C. (January 12, 2022) – On December 9, 2021, Medisca entered into an exclusive global manufacture, supply, license and distribution agreement with Padagis (formerly, the Rx Division of Perrigo) for their ORA Product Line consisting of the following Padagis products in finished form ORA-Plus®, ORA-Sweet®, ORA-Sweet® SF, ORA-Blend®, and ORA-Blend® SF.

Over the last several months, MEDISCA Australia along with other industry leaders have been actively putting forward to the Australian Pharmaceutical Formulary & Handbook (APF), scientific rationale for longer expiry dates for compounded preparations. Medisca is now pleased to see the efforts of the compounding community come to fruition.

Medisca removes potential allergens from topical products and provides essential BUD testing to support clients.

MEDISCA, a global leader in the pharmaceutical compounding industry, is proud to announce a partnership with Ananda Health, the leading CBD provider to US independent pharmacies.

MEDISCA, a global leader in the personalized pharmaceutical industry, has announced that the revolutionary compounding technology, repurposed and optimized over a seven-year period, is available exclusively from MEDISCA, and, therefore, MEDISCA is actively taking steps to inform its competitors about MEDISCA’s expanding patent portfolio relating to its MAZ mixers.

MEDISCA names Reflex Medical as exclusive partner for SAMIX mixer repair and provides unique offer to clients.